Literature DB >> 8075854

Relative roles of nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid in the contractile responses of rat renal arcuate arteries.

X C Wu1, N T Richards, J Michael, E Johns.   

Abstract

1. We have examined the effects of inhibition of nitric oxide synthase, cyclo-oxygenase and lipoxygenase on the responses of renal arcuate arteries of Wistar rats, with and without endothelium, to noradrenaline, potassium chloride, endothelin-1, acetylcholine and sodium nitroprusside. 2. Noradrenaline, potassium chloride and endothelin-1 caused concentration-dependent contraction of the vessels. Indomethacin (14 microM) attenuated the contractile response to noradrenaline and to potassium chloride. The inhibitory effect of indomethacin persisted following endothelial removal. 3. Acetylcholine produced concentration-dependent relaxation of the vessels which was potentiated by indomethacin (14 microM). 4. NG-nitro-L-arginine methyl ester (L-NAME, 100 microM) did not affect the contractile response to either noradrenaline or potassium chloride but abolished relaxation to acetylcholine. In addition, L-NAME abolished the affects of indomethacin on acetylcholine-induced relaxation and noradrenaline- and potassium chloride-induced contraction. 5. BWC755C attenuated noradrenaline and potassium chloride-induced contraction. This effect persisted in the presence of indomethacin. 6. In vessels pretreated with CHAPS, BW755C inhibited both noradrenaline and potassium chloride-induced contraction. In these vessels BW755C had no additional inhibitory effect to indomethacin on noradrenaline- and potassium-induced contraction. 7. Inhibition of nitric oxide synthase with L-NAME (100 microM) attenuated the effect of BW755C on noradrenaline- and potassium-induced contraction. 8. BW755C alone did not affect endothelium-dependent relaxation as assessed by the response to acetylcholine. However, in the presence of indomethacin, BW755C inhibited acetylcholine-induced relaxation. 9. BW755C did not affect endothelium-independent relaxation as assessed by the response to sodium nitroprusside in vessels with or without endothelium. 10. These data support the existence of two vasoconstrictor products of arachidonic acid released during contraction of renal arcuate arteries with noradrenaline and potassium chloride. A cyclooxygenase product which appears to be endothelium-independent and the other an endothelium dependent lipoxygenase product.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075854      PMCID: PMC1910375          DOI: 10.1111/j.1476-5381.1994.tb13081.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Mechanism of action of some inhibitors of endothelium-derived relaxing factor.

Authors:  S Moncada; R M Palmer; R J Gryglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells.

Authors:  F Saito; M T Hori; Y Ideguchi; M Berger; M Golub; N Stern; M L Tuck
Journal:  Hypertension       Date:  1992-08       Impact factor: 10.190

4.  Effects of leukotriene D4 on glomerular dynamics in the rat.

Authors:  K F Badr; B M Brenner; I Ichikawa
Journal:  Am J Physiol       Date:  1987-08

5.  The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation.

Authors:  J A Salmon; P M Simmons; S Moncada
Journal:  J Pharm Pharmacol       Date:  1983-12       Impact factor: 3.765

6.  Bovine and human endothelial cell production of neutrophil chemoattractant activity in response to components of the angiotensin system.

Authors:  H W Farber; D M Center; S Rounds
Journal:  Circ Res       Date:  1985-12       Impact factor: 17.367

7.  Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall.

Authors:  P Henriksson; M Hamberg; U Diczfalusy
Journal:  Biochim Biophys Acta       Date:  1985-04-25

8.  Formation of monohydroxyeicosatetraenoic acids from arachidonic acid by cultured rabbit aortic smooth muscle cells.

Authors:  J Larrue; M Rigaud; G Razaka; D Daret; J Demond-Henri; H Bricaud
Journal:  Biochem Biophys Res Commun       Date:  1983-04-15       Impact factor: 3.575

9.  Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells.

Authors:  G E Revtyak; M J Hughes; A R Johnson; W B Campbell
Journal:  Am J Physiol       Date:  1988-08

10.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

Authors:  T F Lüscher; P M Vanhoutte
Journal:  Hypertension       Date:  1986-04       Impact factor: 10.190

View more
  4 in total

1.  Study of the mechanisms involved in adenosine-5'-O-(2-thiodiphosphate) induced relaxation of rat thoracic aorta and pancreatic vascular bed.

Authors:  B Saïag; D Hillaire-Buys; J Chapal; P Petit; D Pape; B Rault; H Allain; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 2.  Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.

Authors:  Batoule H Majed; Raouf A Khalil
Journal:  Pharmacol Rev       Date:  2012-06-07       Impact factor: 25.468

3.  Bioactive lipid mediators in polycystic kidney disease.

Authors:  Jelena Klawitter; Jost Klawitter; Kim McFann; Alexander T Pennington; Kaleab Z Abebe; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Berenice Gitomer; Uwe Christians; Robert W Schrier
Journal:  J Lipid Res       Date:  2013-12-16       Impact factor: 5.922

4.  Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease.

Authors:  Jelena Klawitter; Iram Zafar; Jost Klawitter; Alexander T Pennington; Jacek Klepacki; Berenice Y Gitomer; Robert W Schrier; Uwe Christians; Charles L Edelstein
Journal:  BMC Nephrol       Date:  2013-07-31       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.